S. Boenzi, F. Deodato, R. Taurisano, D. Martinelli, D. Verrigni et al., A new simple and rapid LC-ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease, Clin. Chim. Acta, vol.437, pp.93-100, 2014.

S. Boenzi, F. Deodato, R. Taurisano, B. M. Goffredo, C. Rizzo et al., Evaluation of plasma cholestane-3beta,5alpha,6beta-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism, J. Lipid Res, vol.57, pp.361-367, 2016.

F. Dalenc, M. Poirot, and S. Silvente-poirot, Dendrogenin A: a mammalian metabolite of cholesterol with tumor suppressor and neurostimulating properties, Curr. Med. Chem, vol.22, pp.3533-3549, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02380776

F. Dalenc, L. Iuliano, T. Filleron, C. Zerbinati, M. Voisin et al., Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: results of the OXYTAM study, J. Steroid Biochem. Mol. Biol, vol.169, pp.210-218, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02380620

P. De-medina, M. R. Paillasse, G. Segala, M. Poirot, and S. Silvente-poirot, Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands, Proc. Natl. Acad. Sci. U. S. A, vol.107, pp.13520-13525, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00519159

P. De-medina, M. R. Paillasse, G. Segala, M. Voisin, L. Mhamdi et al., Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties, Nat. Commun, vol.4, p.1840, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00823974

D. Gangi, I. M. Mazza, T. Fontana, A. Copetti, M. Fusilli et al., Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites, Oncotarget, vol.7, pp.5815-5829, 2016.

S. Dzeletovic, O. Breuer, E. Lund, and U. Diczfalusy, Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry, Anal. Biochem, vol.225, pp.73-80, 1995.

W. J. Griffiths, P. J. Crick, and Y. Wang, Methods for oxysterol analysis: past, present and future, Biochem. Pharmacol, vol.86, pp.3-14, 2013.

W. J. Griffiths, J. Abdel-khalik, P. J. Crick, E. Yutuc, and Y. Wang, New methods for analysis of oxysterols and related compounds by LC-MS, J. Steroid Biochem. Mol. Biol, vol.162, pp.4-26, 2016.

O. Guillemot-legris, V. Mutemberezi, P. D. Cani, G. G. Muccioli, O. Guillemot-legris et al., Obesity is associated with changes in oxysterol metabolism and levels in mice liver, hypothalamus, adipose tissue and plasma, Trends Mol. Med, vol.6, pp.594-614, 2016.

L. Iuliano, F. Micheletta, S. Natoli, S. Ginanni-corradini, M. Iappelli et al., Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status, Anal. Biochem, vol.312, pp.217-223, 2003.

L. Iuliano, P. J. Crick, C. Zerbinati, L. Tritapepe, J. Abdel-khalik et al., Cholesterol metabolites exported from human brain, Steroids, vol.99, pp.189-193, 2015.

X. Jiang, R. Sidhu, F. D. Porter, N. M. Yanjanin, A. O. Speak et al., A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma, J. Lipid Res, vol.52, pp.1435-1445, 2011.

B. E. Kennedy, M. Charman, and B. Karten, Niemann-Pick Type C2 protein contributes to the transport of endosomal cholesterol to mitochondria without interacting with NPC1, J. Lipid Res, vol.53, pp.2632-2642, 2012.

G. Klinke, M. Rohrbach, R. Giugliani, P. Burda, M. R. Baumgartner et al., LC-MS/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases, Clin. Biochem, vol.48, pp.596-602, 2015.

E. Kuhnel, D. D. Laffan, G. C. Lloyd-jones, T. Martinez-del-campo, I. R. Shepperson et al., Mechanism of methyl esterification of carboxylic acids by trimethylsilyldiazomethane, Angew. Chem. Int. Ed. Engl, vol.46, pp.7075-7078, 2007.

W. Kulig, L. Cwiklik, P. Jurkiewicz, T. Rog, and I. Vattulainen, Cholesterol oxidation products and their biological importance, Chem. Phys. Lipids, vol.199, pp.144-160, 2016.

V. Mutemberezi, O. Guillemot-legris, and G. G. Muccioli, Oxysterols: from cholesterol metabolites to key mediators, Prog. Lipid Res, vol.64, pp.152-169, 2016.

M. R. Paillasse, N. Saffon, H. Gornitzka, S. Silvente-poirot, M. Poirot et al., , 2012.

, J. Lipid Res, vol.53, pp.718-725

S. Pajares, A. Arias, J. Garcia-villoria, J. Macias-vidal, E. Ros et al., Cholestane-3beta, 5alpha, 6beta-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency, J. Lipid Res, vol.56, pp.1926-1935, 2015.

M. Poirot and S. Silvente-poirot, Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancer, Biochimie, vol.95, pp.622-631, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00743461

M. Poirot, S. Silvente-poirot, and R. R. Weichselbaum, Cholesterol metabolism and resistance to tamoxifen, Curr. Opin. Pharmacol, vol.12, pp.683-689, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00743466

F. D. Porter, D. E. Scherrer, M. H. Lanier, S. J. Langmade, V. Molugu et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease, Sci. Transl. Med, vol.4, pp.170-175, 2010.

, Quantification of OS in biological matrices after partial or total evaporation. The plasma concentrations of 13 different OS were measured by GC-MS. These included 5,6a-EC, 5,6b-EC, CT and OCDO. Samples were prepared according to either classical methodologies (total evaporation) or by directly injecting the crude product of the TMS derivatization reaction for GC/MS analysis (partial evaporation). A) Results of the GC/MS quantification. B) Graph showing the percentage enrichment between the two procedures

G. Segala, P. De-medina, L. Iuliano, C. Zerbinati, M. R. Paillasse et al., ,6-Epoxycholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells, Biochem. Pharmacol, vol.86, issue.5, pp.175-189, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00822322

S. Silvente-poirot and M. Poirot, Cholesterol epoxide hydrolase and cancer, Curr. Opin. Pharmacol, vol.12, pp.696-703, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00743463

S. Silvente-poirot and M. Poirot, Cancer. Cholesterol and cancer, in the balance, Science, vol.343, pp.1445-1446, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00968924

S. Silvente-poirot, P. De-medina, M. Record, and M. Poirot, From tamoxifen to dendrogenin A: the discovery of a mammalian tumor suppressor and cholesterol metabolite, Biochimie, vol.130, pp.109-114, 2016.

B. Sola, M. Poirot, P. De-medina, S. Bustany, V. Marsaud et al., Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism, Oncotarget, vol.4, pp.911-922, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00968940

M. Voisin, S. Silvente-poirot, and M. Poirot, One step synthesis of 6-oxocholestan-3beta,5alpha-diol, Biochem. Biophys. Res. Commun, vol.446, pp.782-785, 2014.